Cofinimmo Performance degli utili passati
Criteri Il passato verificati 4/6
Gli utili di Cofinimmo sono diminuiti a un tasso medio annuo di -21%, mentre il settore Health Care REITs ha visto gli utili diminuire a un tasso medio annuo di 7.3%. I ricavi sono cresciuti crescere a un tasso medio annuo di 4.5%. Il ritorno sul capitale proprio di Cofinimmo è 5.7% e ha margini netti di 52.9%.
Informazioni chiave
-20.99%
Tasso di crescita degli utili
-26.47%
Tasso di crescita dell'EPS
| Health Care REITs Crescita del settore | 0.61% |
| Tasso di crescita dei ricavi | 4.46% |
| Rendimento del capitale proprio | 5.67% |
| Margine netto | 52.91% |
| Prossimo aggiornamento sugli utili | 23 Jul 2026 |
Aggiornamenti sulle prestazioni recenti
Recent updates
COFB: Aedifica Merger Path And Index Removal Will Shape Balanced Outlook
Analysts have kept their Cofinimmo price target steady at €86.17, citing only small adjustments to the discount rate, revenue growth assumptions, and profit margin forecasts. Their long-term view remains broadly unchanged.COFB: Index Removal And 2026 Meeting Will Shape Balanced Risk Profile
Analysts have kept their Cofinimmo price target broadly steady at about €86.17, with the latest update reflecting slightly adjusted assumptions on discount rate, revenue growth and profit margin that leave the implied P/E multiple close to prior levels. What's in the News Cofinimmo SA is recorded as having been removed as an index constituent, which may affect how index funds and ETFs with rules-based mandates treat the stock (Key Developments).COFB: Index Exit And Governance Meeting Will Frame Balanced Risk Reward
Analysts have kept their price target for Cofinimmo broadly steady at €86.17. This reflects only marginal tweaks to assumptions on discount rate, revenue growth, profit margin and future P/E, rather than any major shift in their view of the shares.COFB: Buy Upgrade And Margin Confidence Will Shape Future Risk Reward
Analysts have lifted their price target on Cofinimmo to €86.17 from €86.17. The recent upgrade to Buy supports a slightly more constructive view on its margin profile and long term earnings multiple.COFB: Buy Upgrade And Fair Value View Will Frame Future Risk Reward
Analysts have nudged their price target on Cofinimmo higher to €86.17, reflecting updated assumptions on discount rates, a move to modest revenue growth, a slightly lower profit margin, and a higher forward P/E, alongside a recent upgrade to Buy from a major research house. Analyst Commentary Recent research adjustments give you a clearer view of how the market is framing Cofinimmo at the current price target of €86.17 and the revised assumptions on growth, margins, and P/E.COFB: Buy Upgrade And Refined Assumptions Will Shape Future Risk Reward Balance
Analysts have nudged their fair value estimate for Cofinimmo higher from about €83.72 to around €86.17, citing updated assumptions on discount rates, revenue trends and future P/E, in line with the recent Buy rating upgrade from Kepler Cheuvreux. Analyst Commentary Bullish Takeaways Bullish analysts see the fair value increase from about €83.72 to around €86.17 as support for the recent rating upgrade, suggesting the current share price offers some valuation headroom relative to their assumptions.COFB: Rating Upgrade And Refined Assumptions Will Shape Future Risk Reward Balance
Analysts have modestly adjusted their price targets on Cofinimmo, reflecting slight tweaks to discount rate, revenue growth and profit margin assumptions. Some now see greater upside potential following recent positive research updates and upgrades to Buy.COFB: Rating Upgrade And Refined Assumptions Will Support Fair Value
Analysts have nudged their fair value target for Cofinimmo higher from €81.77 to €83.72, citing updated assumptions around discount rates, profit margins and future P/E, alongside recent positive Street research support. Analyst Commentary Recent Street research has taken a more constructive stance on Cofinimmo, reflected in the higher fair value target of €83.72.COFB: Rating Upgrade And Stable Cash Flows Will Support Fair Value
Analysts have nudged their fair value estimate for Cofinimmo from €81.41 to €81.77, citing a modestly lower discount rate and slightly refined revenue, margin and future P/E assumptions following recent positive Street research. Analyst Commentary Street research has turned more constructive on Cofinimmo, with some analysts moving to a more positive stance and the fair value estimate edging up to €81.77.COFB: Stable Metrics Will Support Fair Value As Risk Perception Slightly Eases
Analysts have trimmed their price target on Cofinimmo slightly to €81.41 from €81.86. This reflects a modestly lower projected future price to earnings multiple and a marginally reduced discount rate in their valuation models.COFB: Stable Metrics Will Support Fair Value Amid Slight Profitability Improvement
Narrative Update on Cofinimmo Analysts have modestly raised their price target on Cofinimmo to EUR 81.86, citing a slightly lower implied discount rate and improved projected profit margins, while growth expectations and valuation multiples remain largely unchanged. Valuation Changes Fair Value: Unchanged at €81.86 per share, indicating a stable intrinsic value estimate.COFB: Financial Metrics Consistency Will Support Stable Fair Value Outlook
Analysts have maintained their fair value estimate for Cofinimmo at €81.86, citing consistent forecasted financial metrics and only minimal updates to underlying assumptions. Valuation Changes Fair Value Estimate remains unchanged at €81.86.COFB: Revenue and Profit Margin Trends Will Shape Fair Value Outlook
Analysts have slightly increased their price target for Cofinimmo from €80.92 to €81.86. They cite improved revenue growth projections and a marginally lower discount rate as key factors behind the adjustment.Healthcare Real Estate Shift Will Yield Lasting Value
Strategic focus on healthcare real estate and divesting non-core areas aims to improve revenue and optimize net margins.Shareholders Of Cofinimmo (EBR:COFB) Must Be Happy With Their 64% Return
Stock pickers are generally looking for stocks that will outperform the broader market. And the truth is, you can make...Ripartizione dei ricavi e delle spese
Come Cofinimmo guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.
Storico di utili e ricavi
| Data | Ricavi | Utili | Spese G+A | Spese di R&S |
|---|---|---|---|---|
| 31 Mar 26 | 383 | 203 | 11 | 0 |
| 31 Dec 25 | 382 | 213 | 14 | 0 |
| 30 Sep 25 | 390 | 192 | 12 | 0 |
| 30 Jun 25 | 391 | 134 | 13 | 0 |
| 31 Mar 25 | 392 | 111 | 14 | 0 |
| 31 Dec 24 | 392 | 64 | 13 | 0 |
| 30 Sep 24 | 392 | -52 | 12 | 0 |
| 30 Jun 24 | 392 | -41 | 13 | 0 |
| 31 Mar 24 | 391 | -55 | 14 | 0 |
| 31 Dec 23 | 389 | -55 | 14 | 0 |
| 30 Sep 23 | 379 | 49 | 16 | 0 |
| 30 Jun 23 | 379 | 185 | 15 | 0 |
| 31 Mar 23 | 373 | 333 | 14 | 0 |
| 31 Dec 22 | 368 | 483 | 14 | 0 |
| 30 Sep 22 | 367 | 565 | 16 | 0 |
| 30 Jun 22 | 357 | 489 | 14 | 0 |
| 31 Mar 22 | 351 | 382 | 13 | 0 |
| 31 Dec 21 | 343 | 260 | 12 | 0 |
| 30 Sep 21 | 328 | 189 | 15 | 0 |
| 30 Jun 21 | 312 | 155 | 13 | 0 |
| 31 Mar 21 | 276 | 122 | 18 | 0 |
| 31 Dec 20 | 293 | 119 | 10 | 0 |
| 30 Sep 20 | 296 | 170 | 12 | 0 |
| 30 Jun 20 | 266 | 193 | 22 | 0 |
| 31 Mar 20 | 292 | 222 | 9 | 0 |
| 31 Dec 19 | 285 | 205 | 9 | 0 |
| 30 Sep 19 | 241 | 134 | 24 | 0 |
| 30 Jun 19 | 270 | 119 | 8 | 0 |
| 31 Mar 19 | 259 | 105 | 8 | 0 |
| 31 Dec 18 | 263 | 146 | 8 | 0 |
| 30 Sep 18 | 260 | 186 | 8 | 0 |
| 30 Jun 18 | 258 | 170 | 8 | 0 |
| 31 Mar 18 | 264 | 166 | 8 | 0 |
| 31 Dec 17 | 263 | 137 | 8 | 0 |
| 30 Sep 17 | 267 | 121 | 8 | 0 |
| 30 Jun 17 | 267 | 128 | 8 | 0 |
| 31 Mar 17 | 275 | 134 | 8 | 0 |
| 31 Dec 16 | 257 | 97 | 9 | 0 |
| 30 Sep 16 | 253 | 100 | 9 | 0 |
| 30 Jun 16 | 255 | 82 | 9 | 0 |
| 31 Mar 16 | 249 | 110 | 9 | 0 |
| 31 Dec 15 | 255 | 104 | 8 | 0 |
| 30 Sep 15 | 260 | 76 | 8 | 0 |
| 30 Jun 15 | 262 | 66 | 8 | 0 |
Guadagni di qualità: COFB ha guadagni di alta qualità.
Margine di profitto in crescita: Gli attuali margini di profitto netti di COFB (52.9%) COFB sono più alti rispetto allo scorso anno (28.3%).
Flusso di cassa libero e analisi degli utili
Analisi della crescita degli utili nel passato
Andamento degli utili: Gli utili di COFB sono diminuiti del 21% all'anno negli ultimi 5 anni.
Accelerare la crescita: La crescita degli utili di COFB nell'ultimo anno ( 83.2% ) supera la media quinquennale ( -21% all'anno).
Guadagni vs Settore: La crescita degli utili COFB nell'ultimo anno ( 83.2% ) ha superato la percentuale del settore Health Care REITs 68.9%.
Rendimento del capitale proprio
ROE elevato: Il Return on Equity ( 5.7% ) di COFB è considerato basso.
Rendimento delle attività
Rendimento del capitale investito
Scoprire le aziende con forti performance passate
Analisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/05/24 11:45 |
| Prezzo dell'azione a fine giornata | 2026/05/22 00:00 |
| Utili | 2026/03/31 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
Cofinimmo SA è coperta da 20 analisti. 8 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Celine Huynh | Barclays |
| Kai Klose | Berenberg |
| Robert Jones | BNP Paribas |